{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Afimoxifene",
  "nciThesaurus": {
    "casRegistry": "68047-06-3",
    "chebiId": "CHEBI:44616",
    "chemicalFormula": "",
    "definition": "A tamoxifen metabolite with both estrogenic and anti-estrogenic effects.  Afimoxifene has a higher affinity for the estrogen receptor than tamoxifen, and functions as an antagonist in breast cancer cells.",
    "fdaUniiCode": "17197F0KYM",
    "identifier": "C975",
    "preferredName": "Afimoxifene",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1821"
    ],
    "synonyms": [
      "4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol",
      "4-Hydroxy-Tamoxifen",
      "4-Hydroxytamoxifen",
      "4-OHT",
      "4-hydroxytamoxifen",
      "AFIMOXIFENE",
      "Afimoxifene"
    ]
  }
}